Radiotheranostics represents a cutting-edge approach that combines diagnostic imaging and targeted radionuclide therapy to achieve personalized cancer treatment. This integrated modality allows precise tumor localization, real-time monitoring of therapeutic response, and targeted delivery of radiation to malignant cells while sparing normal tissue. Radiotheranostics leverages molecular imaging techniques such as PET and SPECT, coupled with therapeutic radionuclides, to improve patient stratification and treatment outcomes. Emerging applications include peptide receptor radionuclide therapy (PRRT), radiolabeled antibodies, and novel radiotracers for a variety of cancers. This session will delve into the latest advancements, clinical applications, and future perspectives of radiotheranostics, highlighting its potential to revolutionize oncology through precision medicine.
· Principles of radiotheranostics: imaging and therapy in one
· PET, SPECT, and molecular imaging in cancer
· Targeted radionuclide therapies (e.g., PRRT, radiolabeled antibodies)
· Patient selection and personalized treatment strategies
· Challenges, safety considerations, and future prospects